- Title
- Evaluation of the performance of Ortho T. cruzi ELISA test system for the detection of antibodies to Trypanosoma cruzi
- Creator
- Rivera, Hilda; McAuliffe, Isabel; Aderohunmu, TaLesa; Wiegand, Ryan; Montgomery, Susan; Bradbury, Richard; Handali, Sukwan
- Date
- 2022
- Type
- Text; Journal article
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/190051
- Identifier
- vital:17535
- Identifier
-
https://doi.org/10.1128/jcm.00134-22
- Identifier
- ISSN:0095-1137 (ISSN)
- Abstract
- The serologic diagnosis of chronic Chagas disease, caused by infection with the parasite Trypanosoma cruzi, is challenging and lacks a gold-standard assay. To overcome the problem, CDC uses an algorithm that uses two tests on different platforms and applies a third test as a tiebreaker. The Ortho T. cruzi ELISA Test System from Ortho Diagnostics was cleared by FDA for clinical diagnosis usage. We evaluated this test against the CDC algorithm for chronic Chagas disease. We tested several sets of serum specimens: 104 specimens tested positive for T. cruzi specific antibody and 283 (including 30 specimens positive for antibody to Leishmania spp.) tested negative based on the current CDC chronic T. cruzi infection diagnostic testing algorithm. Concordance of the Ortho T. cruzi ELISA Test System with the CDC algorithm result was 90% (95% CI 87 to 93%) overall and 92% (95% CI 89 to 95%) when excluding Leishmania spp. antibody positive specimens. The cross-reactivity of the Ortho T. cruzi ELISA Test System was 37% to Leishmania spp. serologically positive specimens, 1% to specimens from patients diagnosed with other parasitic infections, and 0% against specimens from a US noninfected population. In conclusion, the Ortho T. cruzi ELISA Test System compares well against the CDC diagnostic algorithm for chronic Chagas disease. The availability of this FDA-cleared assay will improve the chronic Chagas disease diagnosis. © 2022 American Society for Microbiology. All rights reserved.
- Publisher
- American Society for Microbiology
- Relation
- Journal of Clinical Microbiology Vol. 60, no. 8 (2022), p.
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- Copyright © 2022 American Society for Microbiology
- Rights
- Open Access
- Subject
- 3202 Clinical sciences; 3207 Medical microbiology; Antibodies detection; Assay performance; ELISA; Trypanosoma cruzi
- Full Text
- Reviewed
- Hits: 450
- Visitors: 463
- Downloads: 57
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published version | 187 KB | Adobe Acrobat PDF | View Details Download |